Drug Trial Radar · NCT07601750
Local Anesthetic Clinical Trial
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
400
Planned (sponsor's estimate)
Start
Jan 7, 2025
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Baylor Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 89 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare several local anesthetics when used during dermatological surgery.
Conditions
- Mohs Micrographic Surgery
- Anesthesia, Local
Interventions
LidocaineDrug
Standard of Care drug
Bupivacaine HydrochlorideDrug
Study Drug
Mepivacaine HydrochlorideDrug
Study Drug
ChlorprocaineDrug
Study Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine if pain increases with local injections at each stage of surgery.Time frame: 5 mins, 15 mins, 20 mins, 25 mins, 30 mins, 45 mins (reconstruction)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Baylor University Medical Center
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.